Defending Eat Out to Help Out – PM's day at Covid inquiry
Arriving amongst protests, Rishi Sunak defends his time as chancellor during the pandemic, as he gives evidence to the Covid inquiry.
Arriving amongst protests, Rishi Sunak defends his time as chancellor during the pandemic, as he gives evidence to the Covid inquiry.
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Even kings have prostate problems. King Charles III was admitted on Friday to The London Clinic, a private hospital, where he underwent a scheduled procedure due to an enlarged prostate, Buckingham Palace confirmed. The treatment was successful and the king is “doing quite well,” a royal source told Fox News Digital. The palace emphasized that…
BBC political editor Chris Mason asked Rishi Sunak if the government was challenging the full release of messages between ministers and officials during the pandemic, to the Covid inquiry, because he was worried about something embarrassing him. The PM said: “Not at all”. He said it was “right that we learn the lessons of Covid”…
Abortions are legal in England if they are performed by a registered medical practitioner and take place within the first 24 weeks of pregnancy. Otherwise, it is illegal to deliberately end a pregnancy and, under the 1861 Offences Against the Person Act, it carries a maximum punishment of life imprisonment.
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…